CompaniesGeneCentric Therapeutics

GeneCentric Therapeutics

active

Durham, NC, United States

Founded 2011

About

Cancer Biomarker, Drug Discovery

Areas of Focus

Categories

DiagnosticsNorth & South Carolina

Team (1)

Michael V. Milburn, PhD

Chief Executive Officer and President

GeneCentric Therapeutics

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

0

As Collaborator

1

Total Enrollment

6

By Phase

NA: 1

By Status

RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2021

2022

2023

2024

2025

2026

Today

Hover over trial bars to see details

Recent Trials

NCT05567627Collaborator

Clinical Exploration of Adeno-associated Virus (AAV) Expressing Human Acid Alpha- Glucosidase (GAA) Gene Therapy for Patients With Infantile-onset Pompe Disease

Started: Aug 1, 2022 · Completed: Sep 30, 2025

Funding History (8)

D

Jun 20, 2025

D

Sep 20, 2022

D

Oct 7, 2021

D

Jan 13, 2021

D

Jan 5, 2017

D/A

Jul 11, 2014

D

Jul 2, 2013

D

Sep 16, 2011

Locations (1)

Headquarters

Durham, NC, United States

Map

Loading map...